CC BY-NC-ND 4.0 · Journal of Clinical Interventional Radiology ISVIR 2024; 08(01): 022-028
DOI: 10.1055/s-0043-1777864
Original Article

Effectiveness of Vertebroplasty and Kyphoplasty for Pain Reduction in Patients with Sarcopenia and Osteoporosis

1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
David Gimarc
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
Nicholas M. Pflederer
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
Jack Pattee
2   University of Colorado Center for Innovative Design and Analysis, Aurora, Colorado, United States
,
Michael Durst
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
MK Jesse
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
James Korf
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
,
Amanda Crawford
3   Department of Radiology and Imaging Sciences, University of Utah School of Medicine, Salt Lake City, Utah, United States
,
Corey K. Ho
1   Department of Radiology, Department of Radiology, University of Colorado School of Medicine, Aurora, Colorado, United States
› Author Affiliations

Abstract

Purpose Vertebral compression fractures (VCFs) are common and associated with high morbidity including severe, debilitating pain. Percutaneous vertebroplasty/kyphoplasty is a demonstrated effective treatment for VCF. Sarcopenia has been implicated as a risk factor for VCF and refracture following cement augmentation, and as a risk factor for procedural complications in some populations; however, the effect of sarcopenia on VCF patients undergoing these procedures is unknown. This study aims to improve outcomes and patient selection by investigating the effects of highly common VCF comorbidities.

Methods A retrospective study was performed of all patients who underwent vertebroplasty/kyphoplasty for treatment of VCF at a single center from 2007 to 2020. Sarcopenia was quantified by normalized total psoas area (TPA) as measured on computed tomography. The effect of sarcopenia, bone density t-score, and clinical and demographic covariates on periprocedural pain scores was evaluated with linear mixed-effects models.

Results Out of 458 procedures performed, 146 and 130 were included in the sarcopenia and osteoporosis analyses, respectively. Sarcopenia and osteoporosis were highly comorbid in VCF patients undergoing vertebroplasty/kyphoplasty. Linear mixed-effects modeling showed no significant association between change in pain score and TPA score (p = 0.827) or bone density t-score (p = 0.818).

Conclusion Postprocedural pain reduction after vertebroplasty/kyphoplasty is not associated with the presence or severity of sarcopenia or osteoporosis/osteopenia. Appropriate patient selection remains critical to optimize the risk–benefit ratio of vertebroplasty/kyphoplasty, and sarcopenia and osteoporosis should not be considered contraindications to these procedures.

Ethical Approval

The study was performed after approval of an institutional review board.




Publication History

Article published online:
30 January 2024

© 2024. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Alsoof D, Anderson G, McDonald CL, Basques B, Kuris E, Daniels AH. Diagnosis and management of vertebral compression fracture. Am J Med 2022; 135 (07) 815-821
  • 2 McCarthy J, Davis A. Diagnosis and management of vertebral compression fractures. Am Fam Physician 2016; 94 (01) 44-50
  • 3 Alexandru D, So W. Evaluation and management of vertebral compression fractures. Perm J 2012; 16 (04) 46-51
  • 4 Hallberg I, Rosenqvist AM, Kartous L, Löfman O, Wahlström O, Toss G. Health-related quality of life after osteoporotic fractures. Osteoporos Int 2004; 15 (10) 834-841
  • 5 Chandra RV, Maingard J, Asadi H. et al. Vertebroplasty and kyphoplasty for osteoporotic vertebral fractures: what are the latest data?. AJNR Am J Neuroradiol 2018; 39 (05) 798-806
  • 6 Clark W, Bird P, Gonski P. et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2016; 388 (10052): 1408-1416
  • 7 Anderson PA, Froyshteter AB, Tontz Jr WL. Meta-analysis of vertebral augmentation compared with conservative treatment for osteoporotic spinal fractures. J Bone Miner Res 2013; 28 (02) 372-382
  • 8 Dong R, Chen L, Tang T. et al. Pain reduction following vertebroplasty and kyphoplasty. Int Orthop 2013; 37 (01) 83-87
  • 9 Gill JB, Kuper M, Chin PC, Zhang Y, Schutt Jr R. Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures. Pain Physician 2007; 10 (04) 583-590
  • 10 Carr D, Cook R, Tong D. et al. Kyphoplasty patient-centered outcomes via questionnaire. J Spine Surg 2018; 4 (02) 328-332
  • 11 Zampini JM, White AP, McGuire KJ. Comparison of 5766 vertebral compression fractures treated with or without kyphoplasty. Clin Orthop Relat Res 2010; 468 (07) 1773-1780
  • 12 Hida T, Shimokata H, Sakai Y. et al. Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women. Eur Spine J 2016; 25 (11) 3424-3431
  • 13 Wang WF, Lin CW, Xie CN. et al. The association between sarcopenia and osteoporotic vertebral compression refractures. Osteoporos Int 2019; 30 (12) 2459-2467
  • 14 Ignasiak D, Valenzuela W, Reyes M, Ferguson SJ. The effect of muscle ageing and sarcopenia on spinal segmental loads. Eur Spine J 2018; 27 (10) 2650-2659
  • 15 Wu WT, Lee TM, Han DS, Chang KV. The prevalence of sarcopenia and its impact on clinical outcomes in lumbar degenerative spine disease-a systematic review and meta-analysis. J Clin Med 2021; 10 (04) 773
  • 16 Jones KI, Doleman B, Scott S, Lund JN, Williams JP. Simple psoas cross-sectional area measurement is a quick and easy method to assess sarcopenia and predicts major surgical complications. Colorectal Dis 2015; 17 (01) O20-O26
  • 17 Bourassa-Moreau É, Versteeg A, Moskven E. et al. Sarcopenia, but not frailty, predicts early mortality and adverse events after emergent surgery for metastatic disease of the spine. Spine J 2020; 20 (01) 22-31
  • 18 Banaszek D, Inglis T, Ailon T. et al. P153. Sarcopenia, independent of age, predicts mortality and acute care adverse events in patients with traumatic spinal cord injury. Spine J 2019;19(09):
  • 19 Moskven E, Bourassa-Moreau É, Charest-Morin R, Flexman A, Street J. The impact of frailty and sarcopenia on postoperative outcomes in adult spine surgery. A systematic review of the literature. Spine J 2018; 18 (12) 2354-2369
  • 20 Delgado DA, Lambert BS, Boutris N. et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev 2018; 2 (03) e088
  • 21 Fearon K, Strasser F, Anker SD. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12 (05) 489-495
  • 22 Hogan WB, Philips A, Alsoof D. et al. Kyphoplasty and vertebroplasty performed by surgeons versus nonsurgeons: trends in procedure rates, complications, and revisions. World Neurosurg 2022; 164: e518-e524
  • 23 Fan X, Li S, Zeng X, Yu W, Liu X. Risk factors for thoracolumbar pain following percutaneous vertebroplasty for osteoporotic vertebral compression fractures. J Int Med Res 2021; 49 (01) 300060521989468
  • 24 Li Y, Yue J, Huang M. et al. Risk factors for postoperative residual back pain after percutaneous kyphoplasty for osteoporotic vertebral compression fractures. Eur Spine J 2020; 29 (10) 2568-2575
  • 25 Kamalian S, Bordia R, Ortiz AO. Post-vertebral augmentation back pain: evaluation and management. AJNR Am J Neuroradiol 2012; 33 (02) 370-375
  • 26 Bo J, Zhao X, Hua Z, Li J, Qi X, Shen Y. Impact of sarcopenia and sagittal parameters on the residual back pain after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fracture. J Orthop Surg Res 2022; 17 (01) 111
  • 27 Martin FC, Ranhoff AH. Frailty and sarcopenia. In: Falaschi P, Marsh D. , eds. Orthogeriatrics: Practical Issues in Geriatrics Springer International Publishing; 2021: 53-65
  • 28 Lau E, Ong K, Kurtz S, Schmier J, Edidin A. Mortality following the diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Am 2008; 90 (07) 1479-1486